(3-Bromo-5-chloropyridin-2-yl)methanamine hydrochloride

Catalog No. :
ACPLHJ503
CAS No. :
1257535-43-5
Molecular Formula :
C6H7BrCl2N2
Molecular Weight :
257.95

IUPAC Name:(3-bromo-5-chloropyridin-2-yl)methanamine hydrochloride

(3-Bromo-5-chloropyridin-2-yl)methanamine hydrochloride structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g95%$88.00Login to see priceIn stockInquiry
5g95%$435.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(3-Bromo-5-chloropyridin-2-yl)methanamine hydrochloride
IUPAC Name(3-bromo-5-chloropyridin-2-yl)methanamine hydrochloride
MDL No.MFCD17214190
Molecular FormulaC6H7BrCl2N2
Molecular Weight257.95
SMILESNCC1=NC=C(Cl)C=C1Br.[H]Cl
InChI KeyKFCMZNYWAVOTOI-UHFFFAOYSA-N
Synonym(3-Bromo-5-chloropyridin-2-yl)methanamine hydrochloride;(3-Bromo-5-chloropyridin-2-yl)methylamine hydrochloride, 3-Bromo-5-chloropicolinylamine hydrochloride;(3-Bromo-5-chloropyridin-2-yl)methanamine HCl;2-Pyridinemethanamine, 3-bromo-5-chloro-, hydrochloride (1:1);(3-Bromo-5-chloropyridin-2-yl)methanamine hydrochloride - [B89379]
CAS No.1257535-43-5

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H315-H319-H335
Precautionary Statement(s)
P261-P264-P271-P280-P302+P352-P304+P340+P312-P305+P351+P338-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACPLHJ503 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACKNBQ537 route compound structure diagram
    ACKNBQ537760207-83-8 In Stock
  2. Then
  3. ACPLHJ503 route product structure diagram
    ACPLHJ5031257535-43-5 In Stock
Inquiry

2. ACPLHJ503 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACPLHJ503 route product structure diagram
    ACPLHJ5031257535-43-5 In Stock
Inquiry

Comments (0)